|
|
Article: Mayo Clinic Study Shows Alternative to Chemotherapy Effective for Newly Diagnosed Multiple Myeloma Patients; Study Finds Oral Combination of Drugs Thalidomide Plus Dexamethasone as Effective as Intravenous Chemotherapy, But Without Side Effects of Nausea, Vomiting and Hair Loss.
- Article from:
- Ascribe Higher Education News Service
- Article date:
- October 30, 2002
CopyrightCOPYRIGHT 2002 AScribe. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Byline: Mayo Clinic
ROCHESTER, Minn., Oct. 30 (AScribe Newswire) -- A Mayo Clinic study indicates patients who are newly diagnosed with multiple myeloma, a cancer of the bone marrow, may have a new and better-tolerated option to intravenous chemotherapy treatment.
The study will be published in the Nov. 1, 2002, issue of the Journal of Clinical Oncology. It is the first study to show that the oral combination of the drugs thalidomide plus dexamethasone provides treatment benefits equal to and in some cases better than the usual chemotherapy regimens administered to patients who are newly diagnosed with multiple myeloma. Previous studies at the University ...